by synergycap1 | Mar 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Below is the letter British Prime Minister Theresa May sent to the president of the European Council, Donald Tusk, declaring the U.K.’s intention to leave the EU. The letter, which was handwritten, triggers Article 50 of the Lisbon Treaty, starting a formal...
by synergycap1 | Mar 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
A government watchdog will examine the taxpayer-funded travel costs when President Donald Trump travels to the Mar-a-Lago resort in Florida and the security procedures surrounding those trips, several congressional Democrats announced Tuesday. The lawmakers requested...
by synergycap1 | Mar 29, 2017 | Bad Credit Loans, Bank Lending, Business Loans, Capital, Non-Bank Loans, Working Capital
Its exploits were the subject of a book and made into into a film, but what secrets does the team’s journey hold for founders and entrepreneurs?
by synergycap1 | Mar 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Finance, Non-Bank Loans, Working Capital
When Greg Kenneally, now 27, became the expert on lacrosse stick maintenance during his college years, few could imagine he was shaping his own career path. Back in 2011, Greg and his twin brother, Mike, were accounting majors in their senior year at Elizabethtown...
by synergycap1 | Mar 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
BERLIN (Reuters) – Volkswagen has filed a legal complaint with a Munich court against the searches carried out by German prosecutors against the law firm it hired to investigate its emissions scandal, a spokesman said.
by synergycap1 | Mar 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
FRANKFURT (Reuters) – A push by the European Medicines Agency to speed up the approval of new drugs that show promise is running into resistance from some of the national agencies that will ultimately decide whether the medicines are worth buying.
